The value of in vitro studies in a case of neonatal diabetes with a novel Kir6.2-W68G mutation
Key Clinical Message: In infants, especially with novel previously undescribed mutations of the KATP channel causing neonatal diabetes, in vitro studies can be used to both predict the response to sulphonylurea treatment and support a second trial of glibenclamide at higher than standard doses if th...
المؤلفون الرئيسيون: | O'Connell, S, Proks, P, Kramer, H, Mattis, K, Sachse, G, Joyce, C, Houghton, J, Ellard, S, Hattersley, A, Ashcroft, F, O'Riordan, S |
---|---|
التنسيق: | Journal article |
منشور في: |
John Wiley and Sons Ltd
2015
|
مواد مشابهة
-
Molecular basis of Kir6.2 mutations causing neonatal diabetes and neonatal diabetes with neurological features
حسب: Proks, P, وآخرون
منشور في: (2005) -
Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.
حسب: Proks, P, وآخرون
منشور في: (2004) -
Interaction between mutations in the slide helix of Kir6.2 associated with neonatal diabetes and neurological symptoms.
حسب: Männikkö, R, وآخرون
منشور في: (2010) -
Permanent neonatal diabetes caused by an in-frame deletion in the N-terminus of Kir6.2
حسب: Craig, T, وآخرون
منشور في: (2008) -
Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects.
حسب: Shimomura, K, وآخرون
منشور في: (2006)